search
Back to results

The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

Primary Purpose

HIV Infections

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Oral Vitamin C
Sponsored by
National Institute of Allergy and Infectious Diseases (NIAID)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for HIV Infections

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Not applicable - Study withdrawn since 04/23/1996

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Secondary Outcome Measures

    Full Information

    First Posted
    November 2, 1999
    Last Updated
    April 11, 2023
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00001070
    Brief Title
    The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
    Official Title
    A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2023
    Overall Recruitment Status
    Withdrawn
    Study Start Date
    undefined (undefined)
    Primary Completion Date
    undefined (undefined)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Name of the Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    HIV Infections

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Intervention Type
    Drug
    Intervention Name(s)
    Oral Vitamin C

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Not applicable - Study withdrawn since 04/23/1996

    12. IPD Sharing Statement

    Learn more about this trial

    The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

    We'll reach out to this number within 24 hrs